Psychopharmacopeia.com is a progressive web application aimed at providing clinicians with fast access to psychiatric drug information.
Quickly find indications (including off-label), dosing, side effects, clinically useful pharmacokinetic and pharmacodynamic information, drug-drug interactions, and prescribing pearls for special populations i.e. pregnant, lactating, patients with renal or hepatic impairment, elderly, etc. At last, a virtual Rolodex of psychopharm information, accessible anywhere and across devices.
This site is being updated almost daily. Esketamine is our most recent addition to the rapidly growing drug database.
Check out our new QT reference page with tables summarizing QT prolongation risk factors, including medication tables for both psych and non-psych meds (with comparison of high vs low risk of QT prolongation of various classes of psych meds).
All drugs in the psychopharm database populate our CYP450 table, organized into substrates, inhibitors, and inducers of the major CYP pathways (1A2, 2D6, 2C9/C19, 3A4).
Converting a patient from one benzodiazepine to another? This benzodiazepine conversion tool shows the equipotent dose of the drug you're converting to, while comparing basic pharmacokinetic and prescribing information side-by-side.
The antipsychotic conversion tool allows for quick calculation of equipotent antipsychotic doses for 20 different antipsychotic medications based on published chlorpromazine equivalents and provides suggested cross-taper schedule for making the switch!
The stimulant dose conversion calculator is still in progress, and so far can convert doses to/from among Ritalin, Adderall, Vyvanse, Dexadrine, and Focalin. Look for updates to this conversion tool soon!
Association of Antipsychotic Polypharmacy vs Monotherapy With Rehospitalization in Schizophrenia
Posted on Tuesday February 19, 2019
This national cohort study examines the use of polypharmacy vs monotherapy as maintenance treatment among adult patients with schizophrenia who have been rehospitalized for psychiatric treatment in Finland.
Efficacy and Safety of Intranasal Esketamine in Depression
Posted on Wednesday January 31, 2018
This randomized clinical trial compares the effects of 3 dose levels of intranasal esketamine with placebo in patients with treatment-resistant depression.
Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood
Posted on Tuesday February 12, 2019
This systematic review and meta-analysis examines the association of cannabis use during adolescence with risk of developing subsequent major depression, anxiety, and suicidal behavior in young adulthood.
Association of Hormonal Contraception With Depression
Posted on Monday October 31, 2016
This nationwide cohort study investigates whether the use of hormonal contraception is positively associated with subsequent use of antidepressants and a diagnosis of depression among women in Denmark.
The Brain and Pornography Consumption
Posted on Monday June 30, 2014
Kühn and Gallinat determine whether frequent pornography consumption is associated with the frontostriatal network.
Developed & Designed by Kevin M. Nasky, D.O. • Built with Bootstrap, PHP & MySQL • Hosted by SiteGround
Last updated March 09 2019 12:10:32. Disclaimer: This website does not provide medical advice, nor is it a substitute for clinical judgment.